Symrise (FRA:SY1) has been assigned a €77.00 ($89.53) price objective by equities research analysts at Sanford C. Bernstein in a report issued on Wednesday, Borsen Zeitung reports. The firm currently has a “neutral” rating on the stock. Sanford C. Bernstein’s target price points to a potential downside of 5.29% from the stock’s current price.

Other analysts also recently issued research reports about the stock. Kepler Capital Markets set a €78.50 ($91.28) target price on shares of Symrise and gave the stock a “neutral” rating in a research report on Tuesday, April 30th. Credit Suisse Group set a €87.00 ($101.16) price objective on shares of Symrise and gave the company a “buy” rating in a report on Friday, August 9th. Morgan Stanley set a €81.00 ($94.19) price objective on shares of Symrise and gave the company a “neutral” rating in a report on Monday, July 15th. JPMorgan Chase & Co. set a €63.00 ($73.26) price objective on shares of Symrise and gave the company a “sell” rating in a report on Wednesday. Finally, Barclays set a €79.00 ($91.86) price objective on shares of Symrise and gave the company a “neutral” rating in a report on Thursday, August 8th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and six have assigned a buy rating to the stock. Symrise has a consensus rating of “Hold” and a consensus price target of €81.78 ($95.09).

FRA:SY1 traded down €1.88 ($2.19) during trading hours on Wednesday, hitting €81.30 ($94.53). 129,198 shares of the company were exchanged. Symrise has a 52-week low of €56.96 ($66.23) and a 52-week high of €73.48 ($85.44). The company’s 50 day moving average is €83.40.

Symrise Company Profile

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Read More: How a Strangle Strategy is different from a Straddle Strategy

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.